Skip to content

Vitamin C Supplement for Lumbar Spine Surgery

Vitamin C Supplementation for Lumbar Spine Surgical Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03918694
Enrollment
55
Registered
2019-04-17
Start date
2019-06-30
Completion date
2022-06-03
Last updated
2025-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Spine Surgery

Brief summary

By doing this study, researchers hope to learn effects of Vit C on lumbar spine surgery outcomes.

Detailed description

Lumbar spine surgeries are common procedures for management of low back pain and their prevalence is increasing. However, their outcomes are less than optimal. An effective and inexpensive solution to minimizing surgical complications and expediting recovery following lumbar spine surgery could be supplementation using high doses of vitamin C, also known as ascorbic acid. Vit C can help reduce oxidative stress and inflammation and improve immune system and body's own chemicals to fight pain. The researchers want to examine if Vit C is effective in decreasing pain and pain medications and improving function. Gaining a better understanding of effects of Vit C on patient recovery may lead to improved outcomes.

Interventions

DIETARY_SUPPLEMENTVitamin C

Daily use of Vit C tablets

DIETARY_SUPPLEMENTPlacebo

Daily use of placebo tablets

Sponsors

University of Kansas Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

Blinded pilot randomized control trial

Intervention model description

2 groups: placebo and Vitamin C

Eligibility

Sex/Gender
ALL
Age
45 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled to have a lumbar spine fusion * Can read and understand the English language * BMI 35 or less

Exclusion criteria

* Patients taking certain medications * lumbar spine laminectomy or discectomy * taking a Vit C supplement * pregnancy * Cauda equine syndrome or spinal tumor * neurological, neurodegenerative or cognitive issues * renal pathology * sickle cell anemia * iron metabolism disorder

Design outcomes

Primary

MeasureTime frameDescription
Recruitment feasibility outcomeup to 7 weeksThe number of participants recruited and enrolled.
Adherence feasibility outcomeup to 7 weeksCalculate adherence in percentage as subjects enrolled versus completed
Pain intensity: numeric rating pain scaleup to 7 weeksself reported 0-10 numeric rating pain scale where 0=no pain and 10=most pain imagined
Pain medication consumptionup to 7 weeksUse of opioids and non-opioids analgesics documented in patients' health records
Functionup to 7 weeksGait distance in feet will be obtained during physical therapy visit
Would healingup to 7 weeksSurgical incision observation

Secondary

MeasureTime frameDescription
Beck depression inventoryup to 7 weeksA standard questionnaire with 1 - 40 points, 1=no depression and 40=extreme depression
Pain catastrophizing scaleup to 7 weeksA standard scale to measure catastrophizing thoughts. Higher numbers indicate greater catastrophizing thoughts
Vit C levelup to 7 weeksSerum level of Vit C in umol/L
Beck anxiety inventoryup to 7 weeksA standard questionnaire with 21 questions. Scores 0-21=low anxiety, scores 22-35=moderate anxiety and scores 36 and above=potentially concerning level of anxiety
2011 Fibromyalgia (FM) surveyup to 7 weeksA standard questionnaire for centralized pain. Scores 3-6 in widespread pain index and 9 or greater in symptom severity suggest widespread pain
fatigue questionnaireup to 7 weeksA standard questionnaire with 10 fatigue related questions. Each measured on 1-5 Likert scale. Higher numbers indicate greater fatigue
Pittsburg sleep scaleup to 7 weeksA standard questionnaires to examine sleep problems. A total of 5 scores or greater indicate poor sleep quality

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026